Imforte Study News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Imforte Study. Real-time updates on events, politics, business and more.

Overview of Second-Line Treatment Options in SCLC

September 15, 2023

Expert oncologists Laurent Greiller, MD, and Christian Grohé, MD, reflect on the current state of second-line treatment options for patients with small cell lung cancer.

Laurent Greiller Christian Groh Evolving Paradigms Second Line Treatment Options Small Cell Lung Cancer Relapsed Refractory Sclc

Source: onclive.com

Clinical Data With Lurbinectedin in Small Cell Lung Cancer

September 15, 2023

Key opinion leaders share a focused discussion on lurbinectedin and its evolving role in small cell lung cancer following frontline therapy.

Evolving Paradigms Data With Lurbinectedin Small Cell Lung Small Cell Lung Cancer Limited Stage Sclc Extensive Stage Sclc

Source: onclive.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Imforte Study News Today

Overview of Second-Line Treatment Options in SCLC

Clinical Data With Lurbinectedin in Small Cell Lung Cancer

Explore More Categories